Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients

Clinical trial NCT00238446 · COMPLETED

Trial details

NCT number: NCT00238446
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS

Start date: 2003-04-01
Primary completion: 2006-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.